<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">The chemical composition of high-frequency CMs were obtained from the TcmSP™ (Traditional Chinese Medicine System Pharmacology Database, 
 <ext-link ext-link-type="uri" xlink:href="http://tcmspw.com/tcmsp.php" id="intref0010" xmlns:xlink="http://www.w3.org/1999/xlink">http://tcmspw.com/tcmsp.php</ext-link>). Meanwhile, important pharmacology-related parameters of compounds were also obtained from TcmSP™, including drug-likeness (DL) and oral bioavailability (OB). The compounds with OB &gt;30% and DL &gt; 0.18 were selected as candidate compounds for further analysis (
 <xref rid="bib22" ref-type="bibr">Wang et al., 2017</xref>). Besides, some compounds with low OB or DL values were also selected for candidate compounds because of their excellent pharmacological activities or high contents (
 <xref rid="bib26" ref-type="bibr">S. J. Yue et al., 2017</xref>). The sdf format of the main active ingredients’ structures were downloaded from PubChem (
 <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/" id="intref0015" xmlns:xlink="http://www.w3.org/1999/xlink">https://pubchem.ncbi.nlm.nih.gov/</ext-link>) as candidates for molecular docking.
</p>
